Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Metabolism Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Spotlight on Genomic Analysis of Rare and Understudied Cancers
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Research

Molecular Cancer Research

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Metabolism Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Spotlight on Genomic Analysis of Rare and Understudied Cancers
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

The AACR remains fully committed to supporting publishing operations throughout this challenging time, while still remaining flexible and supportive of the author, reviewer, and editor communities that we serve. If you have any questions or concerns, please reach out to a member of the AACR publishing staff.
Please visit the COVID-19 & Cancer Resource Center where COVID-related content is freely available.

 

Follow @MCR_AACR on Twitter!

  • MCR Current Cover
    Read the March issue!
  • Rapid Impact
    Rapid Impact: Molecular Profiling of Metastatic Bladder Cancer Early-Phase Clinical Trial Participants Predicts Patient Outcomes
    Omar Alhalabi, et al.
  • Multiorgan Signaling Mobilizes Tumor-Associated Erythroid Cells
    Multiorgan Signaling Mobilizes Tumor-Associated Erythroid Cells Expressing Immune Checkpoint Molecules
    Yasuyo Sano, et al.
  • Metabolomics of Prostate Cancer Gleason Score
    Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum
    Kathryn L. Penney, et al.
  • A New Pipeline to Predict and Confirm Tumor Neoantigens
    A New Pipeline to Predict and Confirm Tumor Neoantigens Predict Better Response to Immune Checkpoint Blockade
    Yelena Lazdun, et al.
  • 1
  • 2
  • 3
  • 4
  • 5

From the Current Issue

  • Cancer Genes and Networks
    MYC Activity Inference Captures Diverse Mechanisms of Aberrant MYC Pathway Activation in Human Cancers
    Evelien Schaafsma, Yanding Zhao, Lanjing Zhang, Yong Li and Chao Cheng
    Mol Cancer Res March 1 2021 19 (3) 414-428; DOI:10.1158/1541-7786.MCR-20-0526

  • Signal Transduction and Functional Imaging
    AXL Inhibition Induces DNA Damage and Replication Stress in Non–Small Cell Lung Cancer Cells and Promotes Sensitivity to ATR Inhibitors
    Kavya Ramkumar, C. Allison Stewart, Kasey R. Cargill, Carminia M. Della Corte, Qi Wang, Li Shen, Lixia Diao, Robert J. Cardnell, David H. Peng, B. Leticia Rodriguez, You-Hong Fan, John V. Heymach, Jing Wang, Carl M. Gay, Don L. Gibbons and Lauren A. Byers
    Mol Cancer Res March 1 2021 19 (3) 485-497; DOI:10.1158/1541-7786.MCR-20-0414

  • Tumor Microenvironment and Immunobiology
    Omega-3 Eicosapentaenoic Acid Reduces Prostate Tumor Vascularity
    Nikunj Gevariya, Gabriel Lachance, Karine Robitaille, Charles Joly Beauparlant, Lisanne Beaudoin, Éric Fournier, Yves Fradet, Arnaud Droit, Pierre Julien, André Marette, Alain Bergeron and Vincent Fradet
    Mol Cancer Res March 1 2021 19 (3) 516-527; DOI:10.1158/1541-7786.MCR-20-0316

  • Tumor Microenvironment and Immunobiology | AuthorChoice
    Hypoxic Induction of Exosome Uptake through Proteoglycan-Dependent Endocytosis Fuels the Lipid Droplet Phenotype in Glioma
    Myriam Cerezo-Magaña, Helena C. Christianson, Toin H. van Kuppevelt, Karin Forsberg-Nilsson and Mattias Belting
    Mol Cancer Res March 1 2021 19 (3) 528-540; DOI:10.1158/1541-7786.MCR-20-0560

See the Table of Contents


Recent Reviews

  • The MEK/ERK Network as a Therapeutic Target in Human Cancer
    Reviews
    The MEK/ERK Network as a Therapeutic Target in Human Cancer
    Renee Barbosa, Lucila A. Acevedo and Ronen Marmorstein
    Mol Cancer Res March 1 2021 19 (3) 361-374; DOI:10.1158/1541-7786.MCR-20-0687

  • Reviews
    Y-Box Binding Protein-1: A Neglected Target in Pediatric Brain Tumors?
    Louisa Taylor, Ian D. Kerr and Beth Coyle
    Mol Cancer Res March 1 2021 19 (3) 375-387; DOI:10.1158/1541-7786.MCR-20-0655

  • Reviews
    Protein Arginine Methyltransferase 5 (PRMT5) and the ERK1/2 & PI3K Pathways: A Case for PRMT5 Inhibition and Combination Therapies in Cancer
    Tzuriel Sapir, David Shifteh, Moshe Pahmer, Sanjay Goel and Radhashree Maitra
    Mol Cancer Res March 1 2021 19 (3) 388-394; DOI:10.1158/1541-7786.MCR-20-0745

OnlineFirst Articles

  • M2-TAM polarization promotes ESCC chemoresistance
    Shotaro Nakajima, et al.
  • HLA-E suppresses immunity in TAP1-deficient tumors
    Xiao Zhang, et al.
  • CF10, A Potent Next-Generation Flouropyrimidine for PDAC
    Alex O. Haber, et al.
  • CAT1+ EVs Promote Angiogenesis in CRC
    Atsushi Ikeda, et al.
Load more

Trending - Altmetric

  • Article has an altmetric score of 26
    Molecular Profiling of Metastatic Bladder Cancer Early-Phase Clinical Trial Participants Predicts Patient Outcomes
    Last mentioned on Wed Mar 03 2021
  • Article has an altmetric score of 7
    Qa-1b modulates resistance to anti-PD-1 immune checkpoint blockade in tumors with defects in antigen processing
    Last mentioned on Sun Mar 07 2021
  • Article has an altmetric score of 5
    Dephosphorylation of the Proneural Transcription Factor ASCL1 Re-Engages a Latent Post-Mitotic Differentiation Program in Neuroblastoma
    Last mentioned on Mon Feb 15 2021
  • Article has an altmetric score of 14
    Understanding TERT Promoter Mutations: A Common Path to Immortality
    Last mentioned on Mon Feb 15 2021
  • Article has an altmetric score of 4
    CREBBP/EP300 Bromodomain Inhibition Affects the Proliferation of AR-Positive Breast Cancer Cell Lines
    Last mentioned on Wed Feb 10 2021
  • See more
Advertisement

Back to top
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Rapid Impact Archive
  • Meeting Abstracts

Information for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCR

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Research
eISSN: 1557-3125
ISSN: 1541-7786

Advertisement